Oct 3, 2020 | Brian Fargus, Caroline Fraker, Conferences, Prescription
MedBen Vice Presidents Caroline Fraker and Brian Fargus were among the featured speakers at the Sherrill-Morgan 7th Annual Healthcare Innovation Conference on Thursday, October 1. In her presentation, Senior Vice President Fraker discussed the potential problems of...
Sep 18, 2020 | Cost Savings, MedBen Rx, Pharmacy Benefits Manager (PBM), Prescription, Rebates, Rx Costs, Specialty Drugs, Transparency
Employers could save billion of dollars every year by avoiding “wasteful drugs,” according to BenefitsPro. Guidelines from Pacific Business Group on Health and and researchers from Johns Hopkins University identified 49 high-price medications with less...
Sep 5, 2020 | Prescription, Research, Specialty Care
Myalept tops the list of the most expensive drugs currently sold in the United States, as compiled by GoodRx. Used to treat leptin deficiency, Myalept carries a list price of $71,306 for a 30-day prescription. Mavenclad, a multiple sclerosis treatment, follows at...
Jul 22, 2020 | Coronavirus, COVID-19, Emergency Room (ER), MedBen Analytics, Prescription
As the world has changed from the pandemic, so too has health care utilization. Comparing the months of January-June 2019 to January-June 2020 for the MedBen block of business, we find that per member: The biggest decreases in utilization are for surgical inpatient...
May 17, 2020 | Alternative Plan Design, Direct-to-Employer Contracting, MedBen University, Prescription, Reference-Based Pricing, Roundtables, Savings, Self-funding, Third party administration
Self-funding provides unique ways to save plans money, and MedBen knows how to deliver those savings, said President & CEO Kurt Harden at the 4th Annual Employer Roundtable Webinar on May 14. “In this time that we’re all trying to look at cost,...
Apr 7, 2020 | Announcements, Consumer-driven Health Plans, Flexible spending accounts (FSAs), Health reimbursement arrangements (HRAs), Health Savings Accounts (HSAs), News, Over-the-counter (OTC) drugs, Prescription, Regulatory
The CARES Act signed into law by President Trump on March 27 permanently reinstates coverage of over-the-counter (OTC) medications as eligible for reimbursement from FSAs, HRAs and HSAs without need for a prescription. Under the reinstated coverage, account funds can...
